Frequency of cardiovascular risk factors and metabolic syndrome in patients with chronic kidney disease
- PMID: 20682757
- PMCID: PMC3006534
- DOI: 10.3121/cmr.2010.892
Frequency of cardiovascular risk factors and metabolic syndrome in patients with chronic kidney disease
Abstract
Objective: Metabolic syndrome is a clustering of cardio-metabolic risk factors. Cardiovascular disease is the main cause of morbidity and mortality in end-stage renal disease. The aim of this study was to elucidate the frequency of traditional and novel cardiovascular and metabolic syndrome risk factors in patients with chronic kidney disease. Identification of these risk factors will allow for precautions to be taken earlier to prevent cardiovascular diseases and metabolic syndrome in chronic kidney disease patients.
Methods: A total of 214 patients (91 females, 123 males, mean age 56.1 ± 14.4 years) with chronic kidney disease who were followed in the Nephrology Department of Istanbul Goztepe Training and Research Hospital were included in the study. Anthropometric and biochemical measurements for cardiovascular risk factors and metabolic syndrome parameters were recorded. Glomerular filtration rates (GFR) were estimated using the Cockroft Gault formula. Metabolic syndrome was defined according to International Diabetes Federation criteria.
Results: Thirty-seven percent of patients with chronic renal failure were found to have three or more major cardiovascular risk factors. Seventy percent of patients were found to have metabolic syndrome. The mean numbers of major cardiovascular risk factors and metabolic syndrome parameters in patients with different GFR stages were: 1.8 ± 1.0, 2.6 ± 1.2 (GFR <15 mL/min per 1.73 m(2), n = 102); 2.4 ± 1.0, 3.0 ± 1.0 (GFR 15-29 mL/min per 1.73 m(2), n = 51 ); 2.5 ± 1.1, 3.3 ± 1.0 (GFR 30-59 mL/min per 1.73 m(2), n = 39); 2.4 ± 1.1, 3.5 ± 0.7 (GFR 60-89 mL/min per 1.73 m(2), n = 22), respectively (P = .001).
Conclusion: Although the frequency of cardiovascular risk factors and metabolic syndrome were high in patients with chronic kidney disease, they were negatively correlated with the stage of renal failure.
Similar articles
-
A population-based survey of Chronic REnal Disease In Turkey--the CREDIT study.Nephrol Dial Transplant. 2011 Jun;26(6):1862-71. doi: 10.1093/ndt/gfq656. Epub 2010 Nov 4. Nephrol Dial Transplant. 2011. PMID: 21051501 Free PMC article.
-
Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population.Kidney Int. 2018 May;93(5):1183-1190. doi: 10.1016/j.kint.2017.11.012. Epub 2018 Feb 1. Kidney Int. 2018. PMID: 29395334
-
Renal function predicts cardiovascular outcomes in southern Italian postmenopausal women.Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):481-6. doi: 10.1097/HJR.0b013e32832b8d87. Eur J Cardiovasc Prev Rehabil. 2009. PMID: 19531955
-
Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.Adv Exp Med Biol. 2017;956:279-306. doi: 10.1007/5584_2016_85. Adv Exp Med Biol. 2017. PMID: 27873229 Review.
-
Chronic renal failure: a cardiovascular risk factor.Kidney Int Suppl. 2005 Dec;(99):S25-9. doi: 10.1111/j.1523-1755.2005.09906.x. Kidney Int Suppl. 2005. PMID: 16336573 Review.
Cited by
-
The metabolic syndrome and severity of diabetic retinopathy.Clin Ophthalmol. 2015 Apr 28;9:757-64. doi: 10.2147/OPTH.S80355. eCollection 2015. Clin Ophthalmol. 2015. PMID: 25995613 Free PMC article.
References
-
- Barrett BJ, Parfrey PS, Morgan J, Barré P, Fine A, Goldstein MB, Handa SP, Jindal KK, Kjellstrand CM, Levin A, Mandin H, Muirhead N, Richardson RM. Prediction of early death in end-stage renal disease patients starting dialysis. Am J Kidney Dis 1997;29:214–222. - PubMed
-
- Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112–119. - PubMed
-
- Foley RN, Wang C, Collins AJ. Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study. Mayo Clin Proc 2005;80:1270–1277. - PubMed
-
- Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001;103:987–992. - PubMed
-
- Covic A, Gusbeth-Tatomir P, Goldsmith D. The challenge of cardiovascular risk factors in end-stage renal disease. J Nephrol 2003;16:476–486. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical